Φορτώνει......
Trimethoprim–sulfamethoxazole and risk of sudden death among patients taking spironolactone
BACKGROUND: Trimethoprim–sulfamethoxazole increases the risk of hyperkalemia when used with spironolactone. We examined whether this drug combination is associated with an increased risk of sudden death, a consequence of severe hyperkalemia. METHODS: We conducted a population-based nested case–contr...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | CMAJ |
|---|---|
| Κύριοι συγγραφείς: | , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
8872147 Canada Inc.
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4347789/ https://ncbi.nlm.nih.gov/pubmed/25646289 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/cmaj.140816 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|